That's the assertion of this article's title:
Are there potential confounders at play here?
|
1
|
|||||||||
|
|
1
|
The fact that these are drugs that are used in hypercholesterolemia is beside the point. They happen to target the mutant p53. It's simply targeting a biosynthetic pathway, shutting it down to prevent cancer growth. Seems like a valid strategy for some cancers, when susceptible. |
||
|
|
|
1
|
Great question. Mind if I revise it slightly? "What are the potential confounders at play here? There are always potential confounders. Surely there are some here. Looking forward to hearing the views of those who have knowledge and/or experience. |
||
|
|
|
1
|
Statins reduce inflammation, that's what gives their positive effects, not reducing cholesterol. The reduced inflammation will help with cancer too, but there are many other ways to reduce inflammation without messing with cholesterol. |
||
|
|
